Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease

American Journal of Medicine

Volumn 126, Issue 2, 2013, Pages 150-161

  Ahmed, Ali ^a,b   Rich, Michael W ^c   Zile, Michael ^d,e   Sanders, Paul W ^a,b   Patel, Kanan ^a   Zhang, Yan ^a   Aban, Inmaculada B ^a   Love, Thomas E ^f   Fonarow, Gregg C ^g   Aronow, Wilbert S ^h   Allman, Richard M ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin receptor blockers; Angiotensin converting enzyme inhibitors; Chronic kidney disease; Diastolic heart failure

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DIASTOLIC HEART FAILURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FAILURE, DIASTOLIC; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENIN-ANGIOTENSIN SYSTEM;

EID: 84872565649     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.06.031     Document Type: Article

References (42)

1. A. Ahmed, R.C. Campbell Epidemiology of chronic kidney disease in heart failure Heart Fail Clin 4 2008 387 399
2. A. Ahmed, M.W. Rich, P.W. Sanders Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study Am J Cardiol 99 2007 393 398
3. A. Ahmed, G.C. Fonarow, Y. Zhang Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease Am J Med 125 2012 399 410
4. G.C. Fonarow, W.G. Stough, W.T. Abraham Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
5. D.W. Kitzman, J.M. Gardin, J.S. Gottdiener Importance of heart failure with preserved systolic function in patients > or = 65 years of age CHS Research Group. Cardiovascular Health Study Am J Cardiol 87 2001 413 419
6. A. Ahmed Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure J Gerontol A Biol Sci Med Sci 60 2005 1339 1344
7. A. Ahmed, G.J. Perry, J.L. Fleg, T.E. Love, D.C. Goff Jr, D.W. Kitzman Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis Am Heart J 152 2006 956 966
8. J.S. Gottdiener, R.L. McClelland, R. Marshall Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function The Cardiovascular Health Study Ann Intern Med 137 2002 631 639
9. J.G. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, J. Taylor The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345
10. S. Yusuf, M.A. Pfeffer, K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
11. B.M. Massie, P.E. Carson, J.J. McMurray Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
12. P.M. Rothwell Treating individuals 2 Subgroup analysis in randomised controlled trials: importance, indications, and interpretation Lancet 365 2005 176 186
13. M.A. Feller, M. Mujib, Y. Zhang Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: findings from the Alabama Heart Failure Project Int J Cardiol 2011 May 26 [Epub ahead of print]
14. A. Ahmed, A. Husain, T.E. Love Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods Eur Heart J 27 2006 1431 1439
15. P.R. Rosenbaum, D.B. Rubin The central role of propensity score in observational studies for causal effects Biometrika 70 1983 41 55
16. D.B. Rubin Using propensity score to help design observational studies: application to the tobacco litigation Health Serv Outcomes Res Methodol 2 2001 169 188
17. C.B. Bowling, M.A. Feller, M. Mujib Relationship between stage of kidney disease and incident heart failure in older adults Am J Nephrol 34 2011 135 141
18. P.P. Pawar, L.G. Jones, M. Feller Association between smoking and outcomes in older adults with atrial fibrillation Arch Gerontol Geriatr 55 2012 85 90
19. M. Mujib, A.A. Rahman, R.V. Desai Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves Am J Cardiol 107 2011 552 557
20. G.S. Filippatos, M.I. Ahmed, J.D. Gladden Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data Eur Heart J 32 2011 712 720
21. G.S. Filippatos, R.V. Desai, M.I. Ahmed Hypoalbuminaemia and incident heart failure in older adults Eur J Heart Fail 13 2011 1078 1086
22. C. Adamopoulos, P. Meyer, R.V. Desai Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study Eur J Heart Fail 13 2011 200 206
23. M.I. Ahmed, M. White, O.J. Ekundayo A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study Eur Heart J 30 2009 2029 2037
24. O.J. Ekundayo, R.M. Allman, P.W. Sanders Isolated systolic hypertension and incident heart failure in older adults: a propensity-matched study Hypertension 53 2009 458 465
25. J.T. Heywood, G.C. Fonarow, C.W. Yancy Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF Circ Heart Fail 3 2010 596 605
26. J.M. Pfeffer, M.A. Pfeffer Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure Am J Med 84 1988 37 44
27. J.G. Cleland, M. Tendera, J. Adamus The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345
28. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
29. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
30. M.R. Zile, W.H. Gaasch, I.S. Anand Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial Circulation 121 2010 1393 1405
31. P. Carson, I. Anand, C. O'Connor Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial J Am Coll Cardiol 46 2005 2329 2334
32. F.F. Hou, X. Zhang, G.H. Zhang Efficacy and safety of benazepril for advanced chronic renal insufficiency N Engl J Med 354 2006 131 140
33. B.J. Hoogwerf Renin-angiotensin system blockade and cardiovascular and renal protection Am J Cardiol 105 2010 30A 35A
34. L.A. Hebert Optimizing ACE-inhibitor therapy for chronic kidney disease N Engl J Med 354 2006 189 191
35. V.J. Dzau, W.S. Colucci, G.H. Williams, G. Curfman, L. Meggs, N.K. Hollenberg Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure N Engl J Med 302 1980 1373 1379
36. C.B. Bowling, P.W. Sanders, R.M. Allman Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial Int J Cardiol 2012 Jan 16 [Epub ahead of print]
37. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
38. P. Tricoci, J.M. Allen, J.M. Kramer, R.M. Califf, S.C. Smith Jr Scientific evidence underlying the ACC/AHA clinical practice guidelines JAMA 301 2009 831 841
39. M. Packer, W.H. Lee, P.D. Kessler, N. Medina, M. Yushak, S.S. Gottlieb Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure J Am Coll Cardiol 10 1987 837 844
40. M. Packer, W.H. Lee, N. Medina, M. Yushak, P.D. Kessler Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure Ann Intern Med 106 1987 346 354
41. R. Clarke, M. Shipley, S. Lewington Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 1999 341 353
42. K. Patel, G.C. Fonarow, D.W. Kitzman Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study Eur J Heart Fail 2012 Jul 3 [Epub ahead of print]